Top 5 Stock Picks of Eli Casdin’s Casdin Capital

3. BioLife Solutions, Inc. (NASDAQ:BLFS)

Casdin Capital’s Stake Value: $104,490,000
Percentage of Casdin Capital’s 13F Portfolio: 8.83%
Number of Hedge Fund Holders: 10

BioLife Solutions, Inc. (NASDAQ:BLFS) develops, produces, and sells instruments for biologically preserving cells and tissues. On August 10, Max Masucci, a Cowen analyst, cut his price objective on BioLife Solutions, Inc. (NASDAQ:BLFS) from $32 to $29 while maintaining an ‘Outperform’ rating for the stock. Although he expected further SMID-cap volatility, the analyst believed the firm had solid long-term growth and profitability prospects.

On October 11, CSafe and BioLife Solutions, Inc. (NASDAQ:BLFS) announced a new partnership to provide a combined global service network to support CGT products with a focus on improved reliability, security, and quality. CSafe is one of the largest active and passive temperature-controlled shipping solutions providers for pharmaceuticals.

According to regulatory data for the second quarter, Casdin Capital owned 7.57 million shares of BioLife Solutions, Inc. (NASDAQ:BLFS) worth $104.49 million. The fund first bought a stake in the firm in the second quarter of 2018. In total, 10 hedge funds were bullish on BioLife Solutions, Inc. (NASDAQ:BLFS) in the second quarter, down from 12 a quarter ago. Casdin Capital is the most significant shareholder of the company.

Follow Biolife Solutions Inc (NASDAQ:BLFS)